UCB Transplant of Inherited Metabolic Diseases with Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

Recruiting

Phase 1

UCB Transplant of Inherited Metabolic Diseases with Administration of Intrathecal UCB Derived Oligodendrocyte-Like CellsUCB Transplant of Inherited Metabolic Diseases with Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

Sponsor:

Joanne Kurtzberg, MD

Code:

NCT02254863

Conditions

Adrenoleukodystrophy

Batten Disease

Mucopolysaccharidosis II

Leukodystrophy, Globoid Cell

Leukodystrophy, Metachromatic

Eligibility Criteria

Sex: All

Age: 1 - 22

Healthy Volunteers: Not accepted

Interventions

DUOC-01

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Joanne Kurtzberg, MD on 2024-09-19.